NasdaqGS - Delayed Quote USD

Privia Health Group, Inc. (PRVA)

Compare
18.14 -0.37 (-2.00%)
At close: September 24 at 4:00 PM EDT
Loading Chart for PRVA
DELL
  • Previous Close 18.51
  • Open 18.61
  • Bid 18.10 x 100
  • Ask 18.15 x 200
  • Day's Range 18.13 - 18.62
  • 52 Week Range 15.92 - 24.35
  • Volume 617,448
  • Avg. Volume 740,746
  • Market Cap (intraday) 2.169B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 151.17
  • EPS (TTM) 0.12
  • Earnings Date Nov 1, 2024 - Nov 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 25.61

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

www.priviahealth.com

1,102

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRVA

View More

Performance Overview: PRVA

Trailing total returns as of 9/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PRVA
21.23%
S&P 500
20.19%

1-Year Return

PRVA
16.13%
S&P 500
32.70%

3-Year Return

PRVA
32.16%
S&P 500
28.86%

5-Year Return

PRVA
21.13%
S&P 500
37.05%

Compare To: PRVA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRVA

View More

Valuation Measures

Annual
As of 9/24/2024
  • Market Cap

    2.17B

  • Enterprise Value

    1.79B

  • Trailing P/E

    151.17

  • Forward P/E

    28.33

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.34

  • Price/Book (mrq)

    3.64

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    89.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.88%

  • Return on Assets (ttm)

    0.80%

  • Return on Equity (ttm)

    2.63%

  • Revenue (ttm)

    1.7B

  • Net Income Avi to Common (ttm)

    14.93M

  • Diluted EPS (ttm)

    0.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    387.35M

  • Total Debt/Equity (mrq)

    1.05%

  • Levered Free Cash Flow (ttm)

    79.28M

Research Analysis: PRVA

View More

Company Insights: PRVA

Research Reports: PRVA

View More

People Also Watch